Gambia vs Singapore: The number of people with susceptibility test result for rifampicin
Gambia
1,175
in 2021
Singapore
1,051
in 2021
Gambia rank
62nd
Singapore rank
65th
The number of people with susceptibility test result for rifampicin over time
- Gambia
- Singapore
How they compare
Gambia currently reports 1,175 against 1,051 in Singapore, a difference of 124.
That makes Gambia's figure about 1.1 times Singapore's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Singapore ahead.
Gambia ranks 62nd and Singapore ranks 65th of 155 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gambia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1 | 1,090 | 1,089 | Singapore |
| 2020s | 646 | 1,058 | 412.5 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Gambia or Singapore?
- Gambia, at 1,175 against 1,051 in Singapore as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Gambia and Singapore?
- 124, with Gambia ahead.
- How many years of comparable data are there for Gambia and Singapore?
- 5 years are reported by both, from 2017 to 2021.
- How do Gambia and Singapore rank globally for the number of people with susceptibility test result for rifampicin?
- Gambia ranks 62nd and Singapore ranks 65th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.